I agree that this site is using cookies. You can find further informations here.
X
Horton, Bethany J.
57  results:
OpenAccess-fulltext X
Search for persons X
?
1

Phase I Study of Entinostat, Atezolizumab, Carboplatin, and..:

Gentzler, Ryan D ; Villaruz, Liza C ; Rhee, John C...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628589/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
2

Acid Ceramidase Inhibitor LCL-805 Antagonizes Akt Signaling..:

Ung, Johnson ; Tan, Su-Fern ; Fox, Todd E...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10634704/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
3

Outcomes From Cytotoxic Chemotherapy Following Progression ..:

Gaughan, Elizabeth M ; Horton, Bethany J
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9096114/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
4

A Global Collaboration to Develop and Pilot Test a Mobile A..:

LeBaron, Virginia T ; Horton, Bethany J ; Adhikari, Abish...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9366104/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
5

CLRM-11 CURRENT STATE OF CLINICAL TRIALS FOR PATIENTS WITH ..:

Elghawy, Omar ; Banfield, Walter ; Horton, Bethany.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354145/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
6

A Phase II study of Dovitinib in Patients With Recurrent or..:

Dillon, Patrick M ; Petroni, Gina R ; Horton, Bethany J...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5540767/.  , 2017
Link: http://www.ncbi.nlm.nih...
 
?
7

Prevalence and Risk Factors for Early, Undesired Weaning At..:

Stuebe, Alison M ; Horton, Bethany J ; Chetwynd, Ellen...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4011403/.  , 2014
Link: http://www.ncbi.nlm.nih...
 
?
8

Standardizing Nasal Nitric Oxide Measurement as a Test for ..:

Leigh, Margaret W ; Hazucha, Milan J ; Chawla, Kunal K...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC.  , 2013
Link: http://www.ncbi.nlm.nih...
 
?
9

Improved recognition of lung function decline as signal of ..:

List, Rhonda ; Solomon, George ; Bichl, Stacy...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10759080/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
10

Operating characteristics are needed to properly evaluate t..:

Wages, Nolan A ; Horton, Bethany Jablonski ; Conaway, Mark R.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8453118/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
11

Bayesian Design for Identifying Cohort-Specific Optimal Dos..:

Horton, Bethany Jablonski ; Wages, Nolan A ; Gentzler, Ryan D
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582706/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
12

Consequences of Performing Parallel Dose Finding Trials in ..:

Horton, Bethany Jablonski ; O'Quigley, John ; Conaway, Mark, R
info:eu-repo/semantics/altIdentifier/doi/10.1093/jncics/pkz013.  , 2019
Link: https://hal.sorbonne-uni..
 
?
13

Consequences of Performing Parallel Dose Finding Trials in ..:

Horton, Bethany Jablonski ; O'Quigley, John ; Conaway, Mark
info:eu-repo/semantics/altIdentifier/doi/10.1093/jncics/pkz013.  , 2019
Link: https://hal.sorbonne-uni..
 
?
14

Consequences of Performing Parallel Dose Finding Trials in ..:

Horton, Bethany Jablonski ; O'Quigley, John ; Conaway, Mark, R
info:eu-repo/semantics/altIdentifier/doi/10.1093/jncics/pkz013.  , 2019
Link: https://hal.sorbonne-uni..
 
?
15

Consequences of Performing Parallel Dose Finding Trials in ..:

Horton, Bethany Jablonski ; O'Quigley, John ; Conaway, Mark R
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6555302/.  , 2019
Link: http://www.ncbi.nlm.nih...
 
1-15